Russian Antitrust Watchdog Warns Teva Over MS Drug

Law360, New York (August 20, 2013, 2:35 PM EDT) -- Russia’s antitrust watchdog said Friday it has warned Teva Pharmaceutical Industries Ltd. not to cut off supplies of its multiple sclerosis drug Copaxone to a local distributor, a move the agency claims endangered patients by blocking supplies to a national medical program.

The Federal Anti-Monopoly Service sent a formal warning to the Israeli drugmaker, saying its conduct had the makings of an antitrust violation under the country's competition law.

Teva's Copaxone, generically known as glatiramer acetate, is an "essential innovative medicine" used to treat the central...
To view the full article, register now.